피부 생검 시장 보고서(2025년)
Skin Biopsy Global Market Report 2025
상품코드 : 1855984
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,661,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,629,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,596,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

피부 생검 시장 규모는 최근 몇 년 동안 강력하게 성장하고 있습니다. 2024년 17억 2,000만 달러로 평가되었고, 2025년에는 18억 6,000만 달러, CAGR 8.4%로 성장할 전망입니다. 역사적인 기간의 성장은 피부암과 만성 피부질환의 유병률 상승, 질병의 조기 발견에 대한 의식의 높아짐, 표준 진단 툴로서의 펀치 생검의 채택, 병원이나 클리닉의 인프라의 확대, 암 검진 프로그램에 대한 정부의 지원책 등에 기인하고 있습니다.

피부 생검 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 CAGR 8.1%로 25억 4,000만 달러로 성장할 전망입니다. 예측기간에 있어서 성장의 원동력은 저침습 진단 절차에 대한 수요 증가, 생검 분석에서의 인공지능의 통합, 피부 질환에 걸리기 쉬운 노인 인구 증가, 신흥국에서의 헬스케어 투자, 원격 피부과 및 원격 진찰 서비스의 성장입니다. 예측기간의 주요 동향으로는 디지털 병리학 플랫폼의 채택, 리퀴드 바이옵시 등의 비침습적 대체법의 이용, 생검 결과에 근거한 맞춤형 치료 계획, 기기 제조업체와 헬스 케어 프로바이더와의 제휴, 휴대 가능하고 환자 친화적인 생검 기기의 개발 등을 들 수 있습니다.

피부 질환의 유병률 증가는 피부 생검 시장의 성장을 가속할 것으로 예측됩니다. 피부 질환은 피부의 기능, 구조, 외관에 영향을 미치는 광범위한 질병을 포함하며, 종종 자극, 염증, 조직의 이상 증식 등의 증상을 나타냅니다. 이러한 질병에는 여드름, 습진, 건선, 피부염, vitiligo, 곰팡이 감염, 사마귀, 피부암 등이 포함됩니다. 피부 장애 증가의 주요 요인은 환경 오염 물질에 대한 노출 증가입니다. 환경 오염 물질은 피부의 장벽 기능을 저하시켜 알레르기 반응과 염증 반응을 일으킬 수 있습니다. 피부 생검은 현미경 분석을 위한 정확한 조직 샘플을 제공함으로써 이러한 질병의 진단을 지원하고 감염, 염증성 질환 및 피부암의 조기 발견을 용이하게 합니다. 예를 들어, 정부기관인 캔서 호주에서는 2023년에 새롭게 약 8,257례의 흑색종 증례가 보고되어, 이 나라의 암 관련 사망 전체의 2.6%를 차지하고 있습니다. 그 결과, 피부 질환 증가율이 피부 생검 시장의 확대에 기여하고 있습니다.

또한 건강 관리 지출 증가도 피부 생검 시장 성장에 기여할 것으로 기대됩니다. 건강 관리 지출은 의료 서비스, 치료, 인프라, 연구 및 건강 성과 개선을 목적으로 하는 공중 보건 프로그램에 할당된 총 재원을 의미합니다. 이 증가의 주된 이유는 만성적인 건강 상태 증가이며, 종종 장기적인 관리와 고액의 개입이 필요합니다. 건강 관리에 대한 투자 확대는 고급 진단 도구에 대한 광범위한 접근과 피부과 서비스의 확대로 이어집니다. 이는 피부 질환의 조기 및 정확한 진단을 가능하게 하고, 환자 관리 및 의료 시스템 전반의 성능을 향상시킵니다. 예를 들어, 2024년 5월 영국 정부 기관인 국가 통계국은 2023년 중 건강 관리 지출에 대해 전년도의 0.9% 증가에 대해 5.6% 증가했다고 보고했습니다. 그 결과, 의료비의 성장은 피부 생검 시장의 개척에 큰 역할을 합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

SHW
영문 목차

영문목차

A skin biopsy is a medical procedure in which a small sample of skin tissue is removed for diagnostic or research purposes. It is used to diagnose skin conditions, including infections, inflammatory disorders, and skin cancers, by examining the cellular structure of the tissue. This procedure helps clinicians determine the nature, severity, and appropriate treatment for various skin abnormalities.

The primary types of skin biopsy are excisional biopsy, incisional biopsy, punch biopsy, shave biopsy, and needle biopsy. Excisional biopsy involves surgically removing an entire lump, lesion, or suspicious tissue area along with a margin of normal surrounding tissue for microscopic examination. Procedure types include surgical biopsy, image-guided biopsy, dermatoscopic biopsy, and endoscopic biopsy. Applications include dermatology, oncology, pathology, clinical research, and cosmetic procedures. Key end-users include hospitals, ambulatory surgical centers (ASCs), diagnostic laboratories, research institutions, and dermatology clinics.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The skin biopsy market research report is one of a series of new reports from The Business Research Company that provides skin biopsy market statistics, including skin biopsy industry global market size, regional shares, competitors with a skin biopsy market share, detailed skin biopsy market segments, market trends and opportunities, and any further data you may need to thrive in the skin biopsy industry. This skin biopsy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The skin biopsy market size has grown strongly in recent years. It will grow from $1.72 billion in 2024 to $1.86 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period is attributed to the rising prevalence of skin cancer and chronic skin disorders, growing awareness of early disease detection, adoption of punch biopsy as a standard diagnostic tool, expansion of hospital and clinic infrastructure, and supportive government initiatives for cancer screening programs.

The skin biopsy market size is expected to see strong growth in the next few years. It will grow to $2.54 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period is driven by increasing demand for minimally invasive diagnostic procedures, integration of artificial intelligence in biopsy analysis, a rising geriatric population susceptible to dermatological conditions, healthcare investments in emerging economies, and growth in teledermatology and remote consultation services. Key trends in the forecast period include the adoption of digital pathology platforms, use of non-invasive alternatives such as liquid biopsy, personalized treatment planning based on biopsy results, collaborations between device manufacturers and healthcare providers, and development of portable, patient-friendly biopsy devices.

The increasing prevalence of skin disorders is expected to drive growth in the skin biopsy market. Skin disorders encompass a broad spectrum of conditions that affect the skin's function, structure, or appearance, often presenting with symptoms such as irritation, inflammation, or abnormal tissue growth. These conditions include acne, eczema, psoriasis, dermatitis, vitiligo, fungal infections, warts, and skin cancer. A significant contributor to the rise in skin disorders is growing exposure to environmental pollutants, which can compromise the skin barrier and trigger allergic or inflammatory responses. Skin biopsy supports the diagnosis of these disorders by providing accurate tissue samples for microscopic analysis, which facilitates early identification of infections, inflammatory conditions, and skin cancers. For example, in 2023, Cancer Australia, a government agency, reported around eight thousand two hundred fifty-seven new melanoma cases, accounting for two point six percent of all cancer-related deaths in the country. As a result, the increasing rate of skin disorders is contributing to the expansion of the skin biopsy market.

The rise in healthcare expenditure is also expected to contribute to the growth of the skin biopsy market. Healthcare expenditure refers to the total financial resources allocated to medical services, treatments, infrastructure, research, and public health programs aimed at improving health outcomes. A key reason for this increase is the growing number of chronic health conditions, which often require long-term care and costly interventions. Greater investment in healthcare leads to broader access to advanced diagnostic tools and expanded dermatological services. This supports early and accurate diagnosis of skin conditions and enhances patient care and overall health system performance. For instance, in May 2024, the Office for National Statistics, a government organization in the United Kingdom, reported a five point six percent increase in healthcare spending during 2023, compared to a zero point nine percent increase in the prior year. Consequently, the growth in healthcare expenditure is playing a significant role in the development of the skin biopsy market.

Leading companies within the skin biopsy market are focusing on the development of advanced technologies, such as automated biopsy systems, to improve diagnostic precision, procedural speed, patient experience, and sample quality. These systems use powered mechanisms instead of manual tools to collect tissue samples with higher accuracy and consistency, which helps reduce operator error and discomfort for patients. For example, in May 2023, Argon Medical Devices Inc., a medical device manufacturer based in the United States, introduced the SuperCore Advantage Semi-Automatic Biopsy Instrument. This device is designed with ergonomic features and advanced needle technology to enhance precision during tissue collection. It offers a specialized needle tip for cleaner samples and a smooth-firing system to improve user control and procedural efficiency.

Major players in the skin biopsy market are Olympus Corporation, Sysmex Corporation, Bio-Rad Laboratories, Exact Sciences Corporation, Cardinal Health Inc., Merit Medical Systems Inc., Abbott Laboratories, Danaher Corporation, Philips Healthcare, Becton, Dickinson and Company (BD), Hologic Inc., Cook Medical, Leica Biosystems Nussloch GmbH, AccuTec Inc., MedicalExpo brands, Delasco, Paramount Surgimed Ltd., Neoteryx, Innovia Medical, and World Precision Instruments.

North America was the largest region in the skin biopsy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in skin biopsy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the skin biopsy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The skin biopsy market includes revenues earned by entities through skin tissue collection procedures, histopathological examination, molecular and immunohistochemistry testing, diagnostic pathology reporting services, and follow-up consultation services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Skin Biopsy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on skin biopsy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for skin biopsy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The skin biopsy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Skin Biopsy Market Characteristics

3. Skin Biopsy Market Trends And Strategies

4. Skin Biopsy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Skin Biopsy Growth Analysis And Strategic Analysis Framework

6. Skin Biopsy Market Segmentation

7. Skin Biopsy Market Regional And Country Analysis

8. Asia-Pacific Skin Biopsy Market

9. China Skin Biopsy Market

10. India Skin Biopsy Market

11. Japan Skin Biopsy Market

12. Australia Skin Biopsy Market

13. Indonesia Skin Biopsy Market

14. South Korea Skin Biopsy Market

15. Western Europe Skin Biopsy Market

16. UK Skin Biopsy Market

17. Germany Skin Biopsy Market

18. France Skin Biopsy Market

19. Italy Skin Biopsy Market

20. Spain Skin Biopsy Market

21. Eastern Europe Skin Biopsy Market

22. Russia Skin Biopsy Market

23. North America Skin Biopsy Market

24. USA Skin Biopsy Market

25. Canada Skin Biopsy Market

26. South America Skin Biopsy Market

27. Brazil Skin Biopsy Market

28. Middle East Skin Biopsy Market

29. Africa Skin Biopsy Market

30. Skin Biopsy Market Competitive Landscape And Company Profiles

31. Skin Biopsy Market Other Major And Innovative Companies

32. Global Skin Biopsy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Skin Biopsy Market

34. Recent Developments In The Skin Biopsy Market

35. Skin Biopsy Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기